Back to HomeBeta

ICD-10 Coding for Glioblastoma Multiforme(C71.0, C71.9)

Complete ICD-10-CM coding and documentation guide for Glioblastoma Multiforme. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

GBMGlioblastomaGrade IV Astrocytoma

Related ICD-10 Code Ranges

Complete code families applicable to Glioblastoma Multiforme

C71.0-C71.9Primary Range

Malignant neoplasm of brain

These codes cover glioblastoma based on the specific location within the brain.

Genetic susceptibility to malignant neoplasm

These codes are used for documenting molecular markers like MGMT methylation.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C71.0Malignant neoplasm of cerebrum, except lobes and ventriclesUse when glioblastoma is confirmed in the frontal lobe.
  • MRI confirmation of tumor location
  • Histopathological confirmation of glioblastoma
C71.9Malignant neoplasm of brain, unspecifiedUse when glioblastoma is confirmed but the specific location is not documented.
  • Histopathological confirmation of glioblastoma
  • IDH-wildtype status confirmation

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for glioblastoma multiforme

Essential facts and insights about Glioblastoma Multiforme

The ICD-10 code for glioblastoma multiforme varies by location: C71.0 for frontal lobe, C71.9 if unspecified.

Primary ICD-10-CM Codes for glioblastoma multiforme

Malignant neoplasm of cerebrum, except lobes and ventricles
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed glioblastoma in frontal lobe via MRI

Applicable To

  • Glioblastoma of frontal lobe

Excludes

  • Benign neoplasm of brain (D33.0)

Clinical Validation Requirements

  • MRI confirmation of tumor location
  • Histopathological confirmation of glioblastoma

Code-Specific Risks

  • Misclassification without specific imaging confirmation

Coding Notes

  • Ensure documentation specifies the exact location and type of glioblastoma.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Cerebral edema

G93.6
Use when cerebral edema is documented alongside glioblastoma.

Unspecified convulsions

R56.9
Use when seizure activity is documented alongside glioblastoma.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Neoplasm of uncertain behavior of brain

D43.0
Use D43.0 when the behavior of the neoplasm is uncertain.

Neoplasm of uncertain behavior of brain, unspecified

D43.2
Use D43.2 when the behavior of the neoplasm is uncertain and location is unspecified.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Glioblastoma Multiforme to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C71.0.

Impact

Clinical: May affect treatment decisions and outcomes., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to incomplete documentation.

Mitigation Strategy

Ensure all molecular tests are documented., Review documentation for completeness before coding.

Impact

Reimbursement: May lead to incorrect DRG assignment and reimbursement issues., Compliance: Non-compliance with coding guidelines requiring molecular marker documentation., Data Quality: Inaccurate data for clinical research and treatment outcomes.

Mitigation Strategy

Ensure IDH status is documented and coded appropriately.

Impact

Failure to document molecular markers can lead to audit findings.

Mitigation Strategy

Implement a checklist for molecular marker documentation in glioblastoma cases.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Glioblastoma Multiforme, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Glioblastoma Multiforme

Use these documentation templates to ensure complete and accurate documentation for Glioblastoma Multiforme. These templates include all required elements for proper coding and billing.

Initial Diagnosis of Glioblastoma

Specialty: Neurology

Required Elements

  • Patient history
  • MRI findings
  • Histopathology results
  • Molecular marker status

Example Documentation

Patient presents with headaches and seizures. MRI shows a 3.5cm ring-enhancing lesion in the right frontal lobe. Biopsy confirms glioblastoma, IDH-wildtype. MGMT promoter is methylated.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Brain tumor with edema.
Good Documentation Example
Glioblastoma IDH-wildtype in right parietal lobe with 1.8cm perilesional vasogenic edema.
Explanation
The good example specifies the tumor type, location, and associated conditions, providing a complete clinical picture.

Need help with ICD-10 coding for Glioblastoma Multiforme? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more